Frontier Medicines | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

8 February 2024

KRAS and conjugates remain hot

The latest clinical study listings reveal KRAS-targeting projects, ADCs and others starting phase 1.

Subscribe to Frontier Medicines